IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic Vasculitis

NCT00307645 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

160

Enrollment

OTHER

Sponsor class

Conditions

ANCA Associated Systemic Vasculitis Including Wegener's
Granulomatosis and Microscopic Polyangiitis and
Renal Limited Vasculitis

Interventions

DRUG: Cyclophosphamide
DRUG: Mycophenolate mofetil
DRUG: Azathioprine
DRUG: Prednisone (and methylprednisolone)

Sponsor

Assistance Publique - Hôpitaux de Paris